InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,815.26
(
-0.76%
)
US TECH 100
19,652.00
(
-1.25%
)
Dow Jones
42,740.42
(
-0.75%
)
Brent Oil
74.18
(
-0.39%
)
Bitcoin
67,378.00
(
0.55%
)
Post# of 253377
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 840
Posts 120569
Boards Moderated 14
Alias Born 09/05/2002

DewDiligence

Member Level

Re: mcbio post# 221425

Tuesday, 10/16/2018 7:07:08 PM

Tuesday, October 16, 2018 7:07:08 PM

Post# of 253377
Re: ENTA's HBV data (ASMB)

On the two slides you referenced (#33-34 from ENTA's latest slide set), I interpret the blank EC50 entries for other companies' HBV candidates to mean that ENTA does not have data available to enter a value. I.e., I do not interpret the blank entries to mean that the other companies' candidates lack activity in the cell line or HBV genotype in question.

If anyone disagrees with the above interpretation, or has other comments on mcbio's post, please reply!

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up